ENDOTAK RELIANCE
Report
- Report Number
- 2124215-2011-10230
- Event Type
- Injury
- Date Received
- July 21, 2011
- Date of Event
- June 3, 2011
- Report Date
- June 16, 2016
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- LWS
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- OTHER
Narratives
AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
ALL AVAILABLE INFORMATION INDICATES THAT THE PRODUCTS REMAIN IN SERVICE. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, THE LEAD WAS RETURNED SEVERED AT 37 AND 60 CM FROM THE IS-1 TERMINAL PIN WITH THE TIP SECTION OF THE LEAD NOT RETURNED. VISUAL INSPECTION NOTED THAT MISSING SETSCREW MARKS ON THE TERMINAL PIN SUGGESTED IMPROPERLY INSERTED LEAD. RESISTANCE AND PRESSURE TESTS WERE COMPLETED ON THE RETURNED PORTIONS TO ASSESS LEAD ELECTRICAL PERFORMANCE AND INSULATION INTEGRITY. MEASUREMENTS THROUGHOUT THESE TESTS WERE WITHIN NORMAL LIMITS. ANALYSIS DETERMINED THAT THE CLINICAL OBSERVATIONS WERE LIKELY DUE TO AN IMPROPERLY INSERTED LEAD INTO DEVICE HEADER.
BOSTON SCIENTIFIC RECEIVED ADDITIONAL INFORMATION THREE MONTHS LATER THAT THIS RIGHT VENTRICULAR DEFIBRILLATION LEAD AND IMPLANTABLE CARDIOVERTER DEFIBRILLATOR CONTINUE TO DISPLAY HIGH OUT OF RANGE PACING IMPEDANCE MEASUREMENTS. THE PRODUCTS REMAIN IMPLANTED AND WILL CONTINUE TO BE MONITORED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
ADDITIONAL INFORMATION WAS RECEIVED THAT THIS PATIENT UNDERWENT A REVISION PROCEDURE. IT WAS REVEALED THAT THE RV LEAD WAS NOT FULLY INSERTED IN THE HEADER OF THE ICD. THE LEAD WAS RE-INSERTED SUCCESSFULLY AND NO FURTHER COMPLICATIONS WERE OBSERVED. NO ADVERSE PATIENT EFFECTS WERE REPORTED. THIS PRODUCT REMAINS IN-SERVICE.
ADDITIONAL INFORMATION WAS RECEIVED THAT THIS SYSTEM CONTINUED TO EXHIBIT OUT OF RANGE IMPEDANCE MEASUREMENTS. THE PATIENT WAS BROUGHT INTO THE CLINIC FOR EVALUATION AND THERE WAS ONE EPISODE OF NOISE STORED. AN X-RAY WAS PERFORMED AND IT WAS REPORTED THAT THERE WAS A POTENTIAL INCOMPLETE CONNECTION ISSUE. THE PATIENT WAS TO UNDERGO A REVISION PROCEDURE IN THE NEAR FUTURE.
NEW INFORMATION RECEIVED INDICATES THAT THIS LEAD WAS EXPLANTED AFTER THE PATIENT'S SYSTEM WAS DOWNGRADED FROM AN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) TO A PACEMAKER.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR DEFIBRILLATION LEAD AND IMPLANTABLE CARDIOVERTER DEFIBRILLATOR DISPLAYED HIGH OUT OF RANGE PACING IMPEDANCE MEASUREMENTS AFTER LESS THAN TWO MONTHS OF IMPLANT TIME. UPON DEVICE INTERROGATION, THE LEAD IMPEDANCE MEASUREMENTS WERE NORMAL. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ENDOTAK RELIANCE | IMPLANTABLE LEAD | LWS | CPI - DEL CARIBE | 0181 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 41 YR | Hospitalization| L| R | E102 |